SC10914 Monotherapy for the mCRPC With g/s BRCA Mutation
NCT04486937
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
90
Enrollment
INDUSTRY
Sponsor class
Conditions
Metastatic Castration Resistant Prostate Cancer
Interventions
DRUG:
S410914 tablet
Sponsor
Jiangxi Qingfeng Pharmaceutical Co. Ltd.